Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hassan M. Heshmati | M | 72 | 15 years | |
| David Pass | M | 56 |
Gelesis Srl
 Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | 8 years |
| Yishai Zohar | M | 61 |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | - |
| Clayton Christopher | M | 51 | - | |
| Kathryn Cavanaugh | F | 50 | 2 years | |
| Stephen M. Muniz | M | - |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | - |
| Alison Bauerlein | F | 42 | 2 years | |
| Giovanni Abbate | M | - |
Gelesis Srl
Gelesis Srl BiotechnologyHealth Technology Gelesis Srl engages in the manufacture, research, and development of treatment solutions and interventions for gastrointestinal diseases. It also develops products and technologies which offers solutions to induce weight loss, improve glycemic control, and manage blood sugar levels in overweight and obese patients, including those with prediabetes and type 2 diabetes. The company was founded in 2009 and is headquartered in Calimera, Italy. | - |
| Katie Sullivan | F | - | 4 years | |
| Angelo Tremblay | M | - | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 7 | 70.00% |
| Italy | 4 | 40.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cosimo Saponaro
- Personal Network
